Meridian Bioscience
VIVO
#4853
Rank
โ‚น125.77 B
Marketcap
โ‚น2,870
Share price
0.00%
Change (1 day)
25.75%
Change (1 year)

Revenue for Meridian Bioscience (VIVO)

Revenue in 2022 (TTM): โ‚น25.70 Billion

According to Meridian Bioscience's latest financial reports the company's current revenue (TTM ) is โ‚น28.13 Billion. In 2021 the company made a revenue of โ‚น23.32 Billion an increase over the revenue in the year 2020 that were of โ‚น21.87 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Meridian Bioscience from 1996 to 2022

Annual revenue

Year Revenue Change
2022 (TTM) โ‚น25.70 B10.24%
2021 โ‚น23.32 B6.59%
2020 โ‚น21.87 B55.78%
2019 โ‚น14.04 B-5.59%
2018 โ‚น14.87 B12.97%
2017 โ‚น13.16 B-0.99%
2016 โ‚น13.30 B3.18%
2015 โ‚น12.89 B5.91%
2014 โ‚น12.17 B4.73%
2013 โ‚น11.62 B18.84%
2012 โ‚น9.78 B13.62%
2011 โ‚น8.60 B39.4%
2010 โ‚น6.17 B-14.93%
2009 โ‚น7.25 B7.81%
2008 โ‚น6.73 B33.94%
2007 โ‚น5.02 B1.14%
2006 โ‚น4.97 B11.54%
2005 โ‚น4.45 B28.17%
2004 โ‚น3.47 B12.42%
2003 โ‚น3.09 B4.61%
2002 โ‚น2.95 B11.75%
2001 โ‚น2.64 B-2.3%
2000 โ‚น2.70 B9.28%
1999 โ‚น2.47 B60.1%
1998 โ‚น1.54 B9.4%
1997 โ‚น1.41 B24.54%
1996 โ‚น1.13 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚น239.46 B 751.19%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น3.577 T 12,615.83%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น1.675 T 5,854.03%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น336.87 B 1,097.41%๐Ÿ‡บ๐Ÿ‡ธ USA